MELLICELL, INC.
M3 platform for generating mature human fat cells in vitro for drug discovery and mechanism-of-action testing
- Sector
- Biotech
- Headquarters
- NEWTON, MA
- Founded
- 2020
- Latest Form D
- $2.9M, Oct 2022
- Total capital
- $3.5M
- Federal grants
- $571K
- 2 awards · 2024
- Rank in peer group#14 of 37
- Private capital raised
- $2.9M
- 1 Form D · last Oct 2022
- 49 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Novel Adipocyte Engineering Technology for Modeling Adipocyte Dysfunction in Human Obesity$296K
- Federal grantNSF · Phase I · SBIR Phase I: Industrial-Scale Technology for Drug Development in Mature Human Fat Cells$275K
- Private capital raisedForm D · SEC · 1st filing$2.9M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 37 peers
Line = medianBiotech · Platform
- Federal grants#14 · top 38%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Benjamin PopeResearcherExecutive Officer, DirectorLinked by $275K in grants as PI
- Prince NnahExecutive Officer, DirectorNamed in SEC Form D filings
- Todd SpaldingDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 8- PendingCell System And Methods Of UseUSPTOApplication 18286077
- PendingMethods And Compositions Of Polycyclic And A Dual Acting Nitroxide Compounds For Treatment Of Fat Cell Associated DiseasesUSPTOApplication PCTUS2024061590
- PendingMethods And Compositions For Treatment Of Obesity And Diseases Associated With Fat Cell EnlargementUSPTOApplication PCTUS2024013317
Show all 8 patent records
- Cell System And Methods Of UseJun 13, 2024 · Application 18286077Pending
- Methods And Compositions Of Polycyclic And A Dual Acting Nitroxide Compounds For Treatment Of Fat Cell Associated DiseasesApplication PCTUS2024061590Pending
- Methods And Compositions For Treatment Of Obesity And Diseases Associated With Fat Cell EnlargementApplication PCTUS2024013317Pending
- Methods And Compositions Of Polycyclic And A Duel Acting Nitroxide Compounds For Treatment Of Fat Cell Associated DiseasesApplication 63612864Pending
- Methods And Compositions For Treatment Of Obesity, Liposarcoma And Polycystic Ovary SyndromeApplication 63441716Pending
- Cell System And Methods Of UseApplication PCTUS2022024061Pending
- Methods And Compositions For Treatment Of Obesity And Diseases Associated With Fat Cell EnlargementApplication 19151297Pending
- Cell System And Methods Of UseApplication 63172990Pending
Related companies, and why
- YOLO IMMUNE INCSimilar federal contract value in Biotech · null in contracts
- EMMYON, INC.Similar federal contract value in Biotech · null in contracts
- TERAPORE TECHNOLOGIES, INC.Similar federal contract value in Biotech · null in contracts
- ViraCyte LLCSimilar federal contract value in Biotech · null in contracts
- Sentia Medical Sciences, Inc.Similar federal contract value in Biotech · null in contracts
- ILUMINOS THERAPEUTICS LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .